HCA Healthcare, Inc.·4

Feb 25, 7:33 PM ET

WATERMAN ROBERT A 4

4 · HCA Healthcare, Inc. · Filed Feb 25, 2021

Insider Transaction Report

Form 4
Period: 2021-02-24
WATERMAN ROBERT A
SVP & General Counsel
Transactions
  • Sale

    Common Stock

    2021-02-24$178.20/sh13,497$2,405,182339,205 total
  • Sale

    Common Stock

    2021-02-24$176.36/sh43,990$7,758,288282,949 total
  • Sale

    Common Stock

    2021-02-24$175.32/sh4,100$718,809278,849 total
  • Sale

    Common Stock

    2021-02-24$177.00/sh12,266$2,171,056326,939 total
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.75 to $178.695, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.72 to $177.71, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.80 to $176.71, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.00 to $175.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_966903

    POA DOCUMENT